Cadrenal Therapeutics (CVKD) Enterprise Value (2022 - 2026)
Cadrenal Therapeutics (CVKD) posted Enterprise Value of -$2.3 million for Q1 2026, up 42.61% sequentially from -$4.0 million in Q4 2025, and up 68.65% YoY from -$1.4 million in Q1 2025.
Cadrenal Therapeutics (CVKD) Enterprise Value (2022 - 2026) Analysis & Trends
Cadrenal Therapeutics has reported Enterprise Value for 5 years, with the latest figure at -$2.3 million in Q1 2026.
- Quarterly Enterprise Value rose 68.65% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.3 million (up 68.65% YoY) and the FY2025 annual result came in at -$4.0 million, up 59.99% from the prior year.
- Enterprise Value climbed to -$2.3 million in Q1 2026 per CVKD's latest filing, from -$4.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$32586.0 in Q4 2022 and troughed at -$10.0 million in Q4 2024.
- A 5-year average of -$5.3 million and a median of -$4.7 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2026: Enterprise Value slumped 25685.61% in 2023, then jumped 68.65% in 2026.
- Over 5 years, Enterprise Value stood at -$32586.0 in 2022, then plunged by 25685.61% to -$8.4 million in 2023, then declined by 19.23% to -$10.0 million in 2024, then jumped by 59.99% to -$4.0 million in 2025, then soared by 42.61% to -$2.3 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$2.3 million, -$4.0 million, and -$3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | Cadrenal Therapeutics | 4.59 Mn | 2.19 Mn | - | -2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.40 Mn |
| Mar 31, 2026 | -2.30 Mn |
| Dec 31, 2025 | -4.01 Mn |
| Sep 30, 2025 | -3.86 Mn |
| Jun 30, 2025 | -5.57 Mn |
| Mar 31, 2025 | -7.34 Mn |
| Dec 31, 2024 | -10.02 Mn |
| Sep 30, 2024 | -4.36 Mn |
| Jun 30, 2024 | -5.04 Mn |
| Mar 31, 2024 | -6.57 Mn |
| Dec 31, 2023 | -8.40 Mn |
| Sep 30, 2023 | -9.11 Mn |
| Jun 30, 2023 | -3.23 Mn |
| Mar 31, 2023 | -4.03 Mn |
| Dec 31, 2022 | -32,586.00 |